Zarei, Iman
Koistinen, Ville M.
Kokla, Marietta
Klåvus, Anton
Babu, Ambrin Farizah
Lehtonen, Marko
Auriola, Seppo
Hanhineva, Kati
Funding for this research was provided by:
European Union’s Horizon 2020 (874739)
European Union’s Horizon 2020 Marie Sklodowska-Curie ITN Programme (813781)
ERA-NET NEURON 2019 Translational Biomarkers program (334814)
Article History
Received: 19 November 2021
Accepted: 29 August 2022
First Online: 2 September 2022
Competing interests
: Kati Hanhineva (KH), Ville M. Koistinen (VMK), Anton Klåvus (AK), and Ambrin Farizah Babu (AFB) are affiliated with Afekta Technologies Ltd. The remaining authors do not have any competing interests.